Epinephrine dysrhythmogenicity is not enhanced by subtoxic bupivacaine in dogs

Anesthesia and Analgesia

Volumn 83, Issue 1, 1996, Pages 62-67

  Kulier, Alexander H ^a   Woehlck, Harvey J ^a   Hogan, Quinn H ^a   Hoffmann, Raymond G ^a   Novalija, Enis ^a   Turner, Lawrence A ^a   Bosnjak, Zeljko J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPIVACAINE; HALOTHANE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART INFARCTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REGIONAL ANESTHESIA; T WAVE;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; DOGS; ELECTROCARDIOGRAPHY; EPINEPHRINE; TACHYCARDIA, VENTRICULAR;

EID: 0029896757     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199607000-00011     Document Type: Article

References (27)

1. Mallampati SR, Liu PL, Knapp RM. Convulsions and ventricular tachycardia from bupivacaine with epinephrine: successful resuscitation. Anesth Analg 1984;63:856-9.
2. Bernards CM, Carpenter RL, Kenter ME, et al. Effect of epinephrine on central nervous system and cardiovascular system toxicity of bupivacaine in pigs. Anesthesiology 1989;71:711-7.
3. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989;69:794-801.
4. Sharrock NE, Mineo R, Urquhart B. Hemodynamic response to low-dose epinephrine infusion during hypotensive epidural anesthesia for total hip replacement. Reg Anesth 1990;15:295-9.
5. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine [editorial], Anesthesiology 1979;51:285-7.
6. Kasten GW, Martin ST. Successful cardiovascular resuscitation after massive intravenous bupivacaine overdosage in anesthetized dogs. Anesth Analg 1985;64:491-7.
7. Kambam JR, Kinney WW, Matsuda F, et al. Epinephrine and phenylephrine increase cardiorespiratory toxicity of intravenously administered bupivacaine in rats. Anesth Analg 1990;70:543-5.
8. Kulier AH, Turner LA, Kampine JP, Bosnjak ZB. Depression of conduction by epinephrine in canine Purkinje fibers exposed to bupivacaine [abstract]. Anesth Analg 1995;80:S257.
9. Freysz M, Timour Q, Bertrix L, et al. Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold. Anesth Analg 1995;80:657-63.
10. Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T. Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology 1987;66:729-36.
11. Gallagher JD, McClernan CA. The effects of halothane on ventricular tachycardia in intact dogs. Anesthesiology 1991;75:866-75.
12. Harris AS. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1950;1:1318-28.
13. Metz S, Maze M. Halothane concentration does not alter the threshold for epinephrine-induced arrhythmias in dogs. Anesthesiology 1985;62:470-4.
14. Eledjam JJ, de la Coussaye JE, Brugada J, et al. Cardiac electrophysiological effects of bupivacaine in the anesthetized dog: relation with plasma concentration. Arch Int Pharmacodyn Ther 1988;295:147-56.
15. Woehlck HJ, Vicenzi MN, Bosnjak ZJ, Atlee JL. Anesthetics and automaticity of dominant and latent pacemakers in chronically instrumented dogs. I. Methodology, conscious state, and halothane anesthesia - comparison with and without muscarinic blockade during exposure to epinephrine. Anesthesiology 1993;79:1304-15.
16. Chapin JC, Kushins LG, Munson ES, Schick LM. Lidocaine, bupivacaine, etidocaine, and epinephrine-induced arrhythmias during halothane anesthesia in dogs. Anesthesiology 1980;52:23-6.
17. Woehlck HJ, Rusy BF, Atlee JD. Comparison of logdose and bracket protocols for determination of epinephrine arrhythmia thresholds in dogs anesthetized with thiopental-halothane. Anesthesiology 1991;75:884-92.
18. 2 anesthesia in the dog. Anesth Analg 1979;58:401-4.
19. Block AB, Covino BG. Effect of local anesthetic agents on cardiac conduction and contractility. Reg Anesth 1981;6:55-61.
20. Heavner JE, Pitkänen MT, Shi B, Rosenberg PH. Resuscitation from bupivacaine-induced asystole in rats: comparison of different cardioactive drugs. Anesth Analg 1995;80:1134-9.
21. Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg 1988;67:1053-8.
22. Tucker GT, Mather LE. Properties, absorption, and disposition of local anesthetic agents. In: Cousins MJ, Bridenbaugh PO, eds. Neural blockade in clinical anesthesia and management of pain. 2nd ed. Philadelphia: JB Lippincott, 1988:47-111.
23. Clarkson CW, Hondeghem LM. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985;62:396-405.
24. Schubert B, VanDongen AM, Kirsch GE, Brown AM. Beta-adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science 1989;245:516-9.
25. Butterworth JET, Browmow RC, Leith JP, et al. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. Anesthesiology 1993;79:88-95.
26. Hasselstrom LJ, Mogensen T, Kehlet H, Christensen NJ. Effects of intravenous bupivacaine on cardiovascular function and plasma catecholamine levels in humans. Anesth Analg 1984;63:1053-8.
27. Bertrix L, Timour Q, Mazze RI, et al. Adverse interaction between bupivacaine and halothane on ventricular contractile force and intraventricular conduction in the dog. Anesth Analg 1991;73:434-40.